Haihao Zhu, MD, PhD
Research Scientist (previously held)
Boston University Chobanian & Avedisian School of Medicine
Pharmacology, Physiology & Biophysics

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Zhu H, Tao Q, Ang TFA, Massaro J, Gan Q, Salim S, Zhu RY, Kolachalama VB, Zhang X, Devine S, Auerbach SH, DeCarli C, Au R, Qiu WQ. Association of Plasma Amylin Concentration With Alzheimer Disease and Brain Structure in Older Adults. JAMA Netw Open. 2019 08 02; 2(8):e199826.View Related Profiles. PMID: 31433485; PMCID: PMC6707010; DOI: 10.1001/jamanetworkopen.2019.9826;
  2. Gan Q, Yao H, Na H, Ballance H, Tao Q, Leung L, Tian H, Zhu H, Wolozin B, Qiu WQ. Effects of Amylin Against Amyloid-ß-Induced Tauopathy and Synapse Loss in Primary Neurons. J Alzheimers Dis. 2019; 70(4):1025-1040.View Related Profiles. PMID: 31306122; PMCID: PMC6833957; DOI: 10.3233/JAD-190161;
  3. Tao Q, Zhu H, Chen X, Stern RA, Kowall N, Au R, Blusztajn JK, Qiu WQ. Pramlintide: The Effects of a Single Drug Injection on Blood Phosphatidylcholine Profile for Alzheimer's Disease. J Alzheimers Dis. 2018; 62(2):597-609.View Related Profiles. PMID: 29480193; PMCID: PMC5956916; DOI: 10.3233/JAD-170948;
  4. Zhu H, Xue X, Wang E, Wallack M, Na H, Hooker JM, Kowall N, Tao Q, Stein TD, Wolozin B, Qiu WQ. Amylin receptor ligands reduce the pathological cascade of Alzheimer's disease. Neuropharmacology. 2017 Jun; 119:170-181.View Related Profiles. PMID: 28363773; PMCID: PMC6511375; DOI: 10.1016/j.neuropharm.2017.03.030;
  5. Zhu H, Stern RA, Tao Q, Bourlas A, Essis MD, Chivukula M, Rosenzweig J, Steenkamp D, Xia W, Mercier GA, Tripodis Y, Farlow M, Kowall N, Qiu WQ. An amylin analog used as a challenge test for Alzheimer's disease. Alzheimers Dement (N Y). 2017 Jan; 3(1):33-43.View Related Profiles. PMID: 28503657; PMCID: PMC5424531; DOI: 10.1016/j.trci.2016.12.002;
  6. Wang E, Zhu H, Wang X, Gower AC, Wallack M, Blusztajn JK, Kowall N, Qiu WQ. Amylin Treatment Reduces Neuroinflammation and Ameliorates Abnormal Patterns of Gene Expression in the Cerebral Cortex of an Alzheimer's Disease Mouse Model. J Alzheimers Dis. 2017; 56(1):47-61.View Related Profiles. PMID: 27911303; PMCID: PMC5331853; DOI: 10.3233/JAD-160677;
  7. Li H, Zhu H, Wallack M, Mwamburi M, Abdul-Hay SO, Leissring MA, Qiu WQ. Age and its association with low insulin and high amyloid-ß peptides in blood. J Alzheimers Dis. 2015; 49(1):129-37. PMID: 26444783; PMCID: PMC4835689; DOI: 10.3233/JAD-150428;
  8. Qiu WQ, Li H, Zhu H, Scott T, Mwamburi M, Rosenberg I, Rosenzweig J. Plasma Amylin and Cognition in Diabetes in the Absence and the Presence of Insulin Treatment. J Diabetes Metab. 2014 Nov; 5(11). PMID: 25750761; PMCID: PMC4350457; DOI: 10.4172/2155-6156.1000458;
  9. Qiu WQ, Zhu H. Amylin and its analogs: a friend or foe for the treatment of Alzheimer's disease? Front Aging Neurosci. 2014; 6:186. PMID: 25120481; PMCID: PMC4114192; DOI: 10.3389/fnagi.2014.00186;
  10. Zhu H, Wang X, Wallack M, Li H, Carreras I, Dedeoglu A, Hur JY, Zheng H, Li H, Fine R, Mwamburi M, Sun X, Kowall N, Stern RA, Qiu WQ. Intraperitoneal injection of the pancreatic peptide amylin potently reduces behavioral impairment and brain amyloid pathology in murine models of Alzheimer's disease. Mol Psychiatry. 2015 Feb; 20(2):252-62.View Related Profiles. PMID: 24614496; PMCID: PMC4161670; DOI: 10.1038/mp.2014.17;
Showing 10 of 16 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 16 publications over 7 distinct years, with a maximum of 5 publications in 2014


Contact for Mentoring:

72 E. Concord St Silvio Conte (K)
Boston MA 02118
Google Map

Zhu's Networks
Click the "See All" links for more information and interactive visualizations
Similar People
Same Department